Delivery Order SPE2DB22D2007-SPE2DB24FJ0SS
- Not listed
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a Delivery Order worth $16,372.34 for the supply of the pharmaceutical product "RUXIENCE 500 MG/50 ML VIAL 50ML." The contract has an ultimate completion date of July 16, 2024. Amerisourcebergen, one of the largest pharmaceutical distribution companies, is providing these medical supplies to the Defense Logistics Agency (DLA) Troop Support Medical. This order is part of a larger Indefinite...
- This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $13,796.78 order is for the supply of RUXIENCE 500 MG/50 ML VIAL 50ML, a pharmaceutical product, to support military treatment programs and facilities. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) awarded...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,028.91 firm fixed price delivery order is for the RUXIENCE 500 MG/50 ML VIAL 50ML pharmaceutical product. The contract has an ultimate completion date of July 11, 2025 and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,728.70 firm fixed price delivery order is for the supply of RUXIENCE 500 MG/50 ML VIAL 50ML, a pharmaceutical product. The contract has an ultimate completion date of December 28, 2023 and was awarded on December 27, 2023. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC)...
- This federal contract award to Amerisourcebergen Drug Corp, through its Corporate Office division, is a Delivery Order with a ceiling value of $7,072.52 for the supply of the pharmaceutical product RUXIENCE 500 MG/50 ML VIAL 50ML. The contract, which has a firm fixed price pricing type, was awarded by the Defense Logistics Agency (DLA) Troop Support Medical and has an ultimate completion date of April 3, 2024. Amerisourcebergen Drug Corp is the prime contractor on this award, which is a child...
- This federal contract award, valued at $8,029.51, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical distribution company AmerisourceBergen Corporation. The contract is a firm fixed price delivery order for the supply of RUXIENCE 500 mg/50 ml vial, a specialty pharmaceutical product, in support of military treatment programs and facilities. The award has a period of performance through March 19, 2024. AmerisourceBergen...
- This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of RUXIENCE 500 MG/50 ML VIAL 50ML. The $21,927.28 firm fixed price delivery order contract has an ultimate completion date of December 13, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp for the supply of Ruxience 500 mg/50 ml vial medical products. The contract has a ceiling value of $9,786.84 and a completion date of August 13, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded this contract without a set-aside designation. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- The Defense Logistics Agency awarded a $2,970.50 firm fixed price delivery order to AmerisourceBergen Drug Corp for Ruxience 500 mg/50 mL vials. This contract, issued on November 20, 2025, represents a child delivery order under AmerisourceBergen's larger indefinite delivery contract (IDC) with DLA Troop Support Medical. The award was made on a competitive basis with no set-aside designation. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania,...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The $9,457.40 contract is for the delivery of RUXIENCE 500 MG/50 ML VIAL 50ML, a pharmaceutical product. AmerisourceBergen Drug Corp is the prime contractor and no set-aside designation was used. This delivery order falls under a larger indefinite delivery contract (IDC) valued up to $999,999,999.00 that was awarded solely to...
- SPE2DB22D2007Indefinite Delivery Contract
- SPE2DB22D2007-SPE2DB24FJ0SSDelivery Order
This federal contract award is a delivery order issued under a single-award indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The IDC, awarded by the Defense Logistics Agency (DLA) Troop Support Medical, has a potential value of $999,999,999.00 and is the primary vehicle for Amerisourcebergen to provide pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. This specific delivery order, valued at $6,620.18, is for the supply of RUXIENCE 500 MG/50 ML VIAL 50ML, a pharmaceutical product, to be delivered by March 20, 2024. The contract does not have any set-aside designations. Amerisourcebergen Drug Corp, as the prime contractor, is responsible for the fulfillment of this order from its Corporate Office in Conshohocken, Pennsylvania.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.6k | 3/19/24 |